Baijin Life Science Holdings (HKSE:01466) 3-Year Book Growth Rate : -4.70% (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Baijin Life Science Holdings 3-Year Book Growth Rate?

Baijin Life Science Holdings's Book Value per Share for the quarter that ended in Sep. 2024 was HK$0.13.

During the past 12 months, Baijin Life Science Holdings's average Book Value per Share Growth Rate was 8.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was -4.70% per year. During the past 5 years, the average Book Value per Share Growth Rate was -34.00% per year. During the past 10 years, the average Book Value per Share Growth Rate was -30.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of Baijin Life Science Holdings was -4.70% per year. The lowest was -54.10% per year. And the median was -25.30% per year.

Competitive Comparison of Baijin Life Science Holdings's 3-Year Book Growth Rate

For the Luxury Goods subindustry, Baijin Life Science Holdings's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baijin Life Science Holdings's 3-Year Book Growth Rate Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Baijin Life Science Holdings's 3-Year Book Growth Rate falls into.

Baijin Life Science Holdings 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Baijin Life Science Holdings (HKSE:01466) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Baijin Life Science Holdings 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Baijin Life Science Holdings's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Baijin Life Science Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Baijin Life Science Holdings Ltd (HKSE:01466) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

MNNGF:USA

Address

66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG

Website

http://www.affluent-partners.com

Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.

Executives

Pacific Wish Limited
Chan Vincent Wing Sing
Hui Ka Man Emily
Su Yaoyao	2201 Interest of corporation controlled by you
Ketto Inform Limited	2101 Beneficial owner

Baijin Life Science Holdings Headlines

No Headlines